RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Oropharyngeal Neoplasms
Accession: DOID:9000906
browse the term
Definition: Tumors or cancer of the OROPHARYNX.
Synonyms: exact_synonym: Oropharyngeal Neoplasm; oropharynx neoplasm; oropharynx neoplasms
primary_id: MESH:D009959
alt_id: RDO:0006247
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27749845
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27749845
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27749845
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
NDRG1
N-myc downstream regulated 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22972152
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
TP53
tumor protein p53
disease_progression
IEP
RGD
PMID:11072161
RGD:8547874
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
AQP1
aquaporin 1 (Colton blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
G
ARID1A
AT-rich interaction domain 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 1:26,696,015...26,782,104
Ensembl chr 1:26,693,236...26,782,104
G
ARID2
AT-rich interaction domain 2
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma
ClinVar
NCBI chr12:45,729,706...45,908,037
Ensembl chr12:45,729,706...45,908,040
G
ARID4B
AT-rich interaction domain 4B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 1:235,166,902...235,328,179
Ensembl chr 1:235,131,634...235,328,219
G
ARID5B
AT-rich interaction domain 5B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
G
ASPM
assembly factor for spindle microtubules
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 1:197,084,127...197,146,669
Ensembl chr 1:197,084,121...197,146,694
G
ATM
ATM serine/threonine kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
G
ATR
ATR serine/threonine kinase
treatment
IMP
RGD
PMID:32001675
RGD:150340693
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
G
ATRX
ATRX chromatin remodeler
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr X:77,504,880...77,786,216
Ensembl chr X:77,504,880...77,786,233
G
BAP1
BRCA1 associated deubiquitinase 1
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma ClinVar Annotator: match by term: Adenocystic carcinoma
ClinVar
PMID:21642991 PMID:24894717 PMID:26166446 PMID:26452128 PMID:28492532
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
G
BCL11A
BCL11 transcription factor A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 2:60,450,520...60,553,924
Ensembl chr 2:60,450,520...60,554,467
G
BCOR
BCL6 corepressor
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenoid cystic carcinoma
CTD ClinVar
PMID:23685749
NCBI chr X:40,051,246...40,177,329
Ensembl chr X:40,049,815...40,177,329
G
BCORL1
BCL6 corepressor like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr X:129,980,313...130,058,071
Ensembl chr X:129,981,107...130,058,071
G
BRCA1
BRCA1 DNA repair associated
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
BRD1
bromodomain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr22:49,773,278...49,827,873
Ensembl chr22:49,773,278...49,827,873
G
CCND1
cyclin D1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CDH1
cadherin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17520682
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CMTR2
cap methyltransferase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr16:71,281,392...71,289,722
Ensembl chr16:71,281,389...71,289,715
G
CNTN6
contactin 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 3:1,093,024...1,404,217
Ensembl chr 3:1,092,658...1,404,217
G
CREBBP
CREB binding protein
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocystic carcinoma
CTD ClinVar
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
G
DAPK1
death associated protein kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
G
DTL
denticleless E3 ubiquitin protein ligase homolog
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 1:212,035,748...212,105,013
Ensembl chr 1:212,035,553...212,107,400
G
DTX4
deltex E3 ubiquitin ligase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr11:59,171,430...59,208,588
Ensembl chr11:59,171,430...59,208,588
G
EFHD1
EF-hand domain family member D1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 2:232,606,057...232,682,776
Ensembl chr 2:232,606,057...232,682,776
G
EN1
engrailed homeobox 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 2:118,842,171...118,847,648
Ensembl chr 2:118,842,171...118,847,648
G
EP300
E1A binding protein p300
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
G
ERBIN
erbb2 interacting protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 5:65,926,575...66,082,546
Ensembl chr 5:65,883,128...66,082,546
G
ESPL1
extra spindle pole bodies like 1, separase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr12:53,268,299...53,293,638
Ensembl chr12:53,268,299...53,293,638
G
FANCA
FA complementation group A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr16:89,737,549...89,816,647
Ensembl chr16:89,726,683...89,816,977
G
FAT1
FAT atypical cadherin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 4:186,587,794...186,726,696
Ensembl chr 4:186,587,794...186,726,722
G
FBXW7
F-box and WD repeat domain containing 7
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocystic carcinoma
CTD ClinVar
PMID:23685749 PMID:26619011
NCBI chr 4:152,320,544...152,536,092
Ensembl chr 4:152,320,544...152,536,092
G
FGF16
fibroblast growth factor 16
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr X:77,447,389...77,457,278
Ensembl chr X:77,447,389...77,457,278
G
FGFR2
fibroblast growth factor receptor 2
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma
ClinVar
PMID:26619011
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
FGFR4
fibroblast growth factor receptor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 5:177,086,915...177,098,144
Ensembl chr 5:177,086,905...177,098,144
G
FOXO3
forkhead box O3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
G
FOXP2
forkhead box P2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 7:114,086,327...114,693,765
Ensembl chr 7:114,086,327...114,693,772
G
GAS2
growth arrest specific 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr11:22,626,002...22,813,055
Ensembl chr11:22,625,509...22,813,001
G
GAS6
growth arrest specific 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr13:113,820,549...113,864,076
Ensembl chr13:113,820,549...113,864,076
G
GINS2
GINS complex subunit 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
G
H1-4
H1.4 linker histone, cluster member
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 6:26,156,329...26,157,115
Ensembl chr 6:26,156,329...26,157,115
G
H2AC16
H2A clustered histone 16
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 6:27,865,317...27,865,798
Ensembl chr 6:27,865,317...27,865,798
G
HOMER3
homer scaffold protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr19:18,929,201...18,941,217
Ensembl chr19:18,929,201...18,941,261
G
HRAS
HRas proto-oncogene, GTPase
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocystic carcinoma
CTD ClinVar
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22926243 PMID:23093928 PMID:23429430 PMID:23685749 PMID:23751039 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25914166 PMID:26467025 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31394527 PMID:31775759 PMID:33372952 PMID:34008892 More...
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
IAGP
ClinVar Annotator: match by term: Adenocystic carcinoma
ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 More...
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
G
IGFBP2
insulin like growth factor binding protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
G
IL17RD
interleukin 17 receptor D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 3:57,089,982...57,170,317
Ensembl chr 3:57,089,982...57,170,306
G
INSRR
insulin receptor related receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 1:156,840,063...156,859,117
Ensembl chr 1:156,840,063...156,859,117
G
IRX4
iroquois homeobox 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 5:1,877,413...1,887,179
Ensembl chr 5:1,877,413...1,887,236
G
ISYNA1
inositol-3-phosphate synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr19:18,434,388...18,438,133
Ensembl chr19:18,434,388...18,438,167
G
ITGB4
integrin subunit beta 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
G
JAG1
jagged canonical Notch ligand 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
G
JAK3
Janus kinase 3
IAGP
ClinVar Annotator: match by term: Adenocystic carcinoma
ClinVar
PMID:14615376 PMID:28492532 PMID:33040328
NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
G
JMJD1C
jumonji domain containing 1C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr10:63,167,225...63,521,890
Ensembl chr10:63,167,221...63,521,850
G
KANSL1
KAT8 regulatory NSL complex subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr17:46,029,916...46,225,367
Ensembl chr17:46,029,916...46,225,389
G
KAT6A
lysine acetyltransferase 6A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 8:41,929,479...42,051,987
Ensembl chr 8:41,929,479...42,051,994
G
KDM6A
lysine demethylase 6A
exacerbates
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:mutations:multiple: (human) DNA:splice-site mutation, missense mutations:splice junction, CDS:multiple: (human)
CTD RGD
PMID:23685749 PMID:31483290 PMID:23685749
RGD:150429736 , RGD:150429732
NCBI chr X:44,873,188...45,112,779
Ensembl chr X:44,873,188...45,112,779
G
KDM6B
lysine demethylase 6B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr17:7,834,217...7,854,796
Ensembl chr17:7,834,217...7,854,796
G
KMT2C
lysine methyltransferase 2C
disease_progression
EXP IAGP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23685749 PMID:31483290
RGD:150429736
NCBI chr 7:152,134,925...152,436,003
Ensembl chr 7:152,134,922...152,436,644
G
KRAS
KRAS proto-oncogene, GTPase
IAGP
ClinVar Annotator: match by term: Adenocystic carcinoma
ClinVar
PMID:6695174 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16618717 PMID:17384584 PMID:17704260 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21975775 PMID:22722830 PMID:23182985 PMID:23406027 PMID:25157968 PMID:26242988 PMID:28492532 More...
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
G
KRT15
keratin 15
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr17:41,513,745...41,518,890
Ensembl chr17:41,513,745...41,522,529
G
KRT5
keratin 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
G
LRRC56
leucine rich repeat containing 56
IAGP
ClinVar Annotator: match by term: Adenocystic carcinoma
ClinVar
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22926243 PMID:23093928 PMID:23429430 PMID:23751039 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25914166 PMID:26467025 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31394527 PMID:31775759 PMID:33372952 PMID:34008892 More...
NCBI chr11:506,462...554,912
Ensembl chr11:537,527...554,912
G
MAGI1
membrane associated guanylate kinase, WW and PDZ domain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
G
MAGI2
membrane associated guanylate kinase, WW and PDZ domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 7:78,017,055...79,453,667
Ensembl chr 7:78,017,055...79,453,667
G
MAML3
mastermind like transcriptional coactivator 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 4:139,716,753...140,154,184
Ensembl chr 4:139,716,753...140,154,184
G
MAP2K2
mitogen-activated protein kinase kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
G
MARCKS
myristoylated alanine rich protein kinase C substrate
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MARK2
microtubule affinity regulating kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr11:63,839,110...63,911,020
Ensembl chr11:63,838,928...63,911,020
G
MECOM
MDS1 and EVI1 complex locus
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma
ClinVar
NCBI chr 3:169,083,507...169,663,712
Ensembl chr 3:169,083,499...169,663,775
G
MGA
MAX dimerization protein MGA
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr15:41,621,224...41,769,940
Ensembl chr15:41,621,134...41,773,081
G
MIER2
MIER family member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr19:305,573...344,796
Ensembl chr19:305,573...344,815
G
MLC1
modulator of VRAC current 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr22:50,059,391...50,085,875
Ensembl chr22:50,059,391...50,085,426
G
MORF4L1
mortality factor 4 like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr15:78,872,890...78,898,139
Ensembl chr15:78,810,487...78,903,078
G
MYB
MYB proto-oncogene, transcription factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749 PMID:26829750
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYBL1
MYB proto-oncogene like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 8:66,562,175...66,613,218
Ensembl chr 8:66,562,175...66,614,247
G
MYCBP
MYC binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 1:38,862,490...38,873,378
Ensembl chr 1:38,862,493...38,873,368
G
MYCN
MYCN proto-oncogene, bHLH transcription factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 2:15,940,550...15,947,004
Ensembl chr 2:15,940,550...15,947,007
G
NETO2
neuropilin and tolloid like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr16:47,077,703...47,143,945
Ensembl chr16:47,077,703...47,143,945
G
NFIB
nuclear factor I B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 9:14,081,843...14,532,077
Ensembl chr 9:14,081,843...14,398,983
G
NOTCH1
notch receptor 1
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenoid cystic carcinoma
CTD ClinVar
PMID:23685749
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NSD1
nuclear receptor binding SET domain protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 5:177,131,798...177,300,213
Ensembl chr 5:177,131,830...177,300,213
G
NTRK3
neurotrophic receptor tyrosine kinase 3
treatment
IMP
RGD
PMID:23027130
RGD:150519921
NCBI chr15:87,859,751...88,256,739
Ensembl chr15:87,859,751...88,256,791
G
PCSK1N
proprotein convertase subtilisin/kexin type 1 inhibitor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr X:48,831,096...48,835,610
Ensembl chr X:48,831,096...48,835,610
G
PDZK1
PDZ domain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocystic carcinoma
CTD ClinVar
PMID:15930273 PMID:17376864 PMID:18074223 PMID:19366826 PMID:22120714 PMID:22658544 PMID:22949682 PMID:23685749 PMID:23946963 PMID:24033266 PMID:24782230 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27631024 PMID:28151489 PMID:28492532 PMID:29446767 PMID:34008892 More...
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
G
PTEN
phosphatase and tensin homolog
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
PYGB
glycogen phosphorylase B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr20:25,248,085...25,298,012
Ensembl chr20:25,248,085...25,298,012
G
RBFOX2
RNA binding fox-1 homolog 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr22:35,738,736...36,028,824
Ensembl chr22:35,738,736...36,028,824
G
SERPINF1
serpin family F member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
G
SETD2
SET domain containing 2, histone lysine methyltransferase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 3:47,016,436...47,164,840
Ensembl chr 3:47,016,428...47,164,113
G
SF3B1
splicing factor 3b subunit 1
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma
ClinVar
PMID:25741868 PMID:26619011
NCBI chr 2:197,389,784...197,435,093
Ensembl chr 2:197,388,515...197,435,079
G
SLC24A3
solute carrier family 24 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr20:19,212,642...19,722,926
Ensembl chr20:19,212,642...19,722,926
G
SLC3A2
solute carrier family 3 member 2
disease_progression
IEP
RGD
PMID:23516127
RGD:151361211
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC7A5
solute carrier family 7 member 5
disease_progression
IEP
RGD
PMID:23516127
RGD:151361211
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507
G
SMARCA2
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenoid cystic carcinoma
CTD ClinVar
PMID:23685749
NCBI chr 9:2,015,347...2,193,620
Ensembl chr 9:1,980,290...2,193,624
G
SMARCB1
SWI/SNF related BAF chromatin remodeling complex subunit B1
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma
ClinVar
NCBI chr22:23,786,966...23,838,009
Ensembl chr22:23,786,931...23,838,009
G
SMARCE1
SWI/SNF related BAF chromatin remodeling complex subunit E1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr17:40,624,962...40,647,818
Ensembl chr17:40,624,962...40,648,654
G
SMC1A
structural maintenance of chromosomes 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr X:53,374,149...53,422,728
Ensembl chr X:53,374,149...53,422,728
G
SON
SON DNA and RNA binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr21:33,543,038...33,577,481
Ensembl chr21:33,543,038...33,577,481
G
SOX11
SRY-box transcription factor 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 2:5,692,384...5,701,385
Ensembl chr 2:5,692,384...5,701,385
G
SOX4
SRY-box transcription factor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
G
SRCAP
Snf2 related CREBBP activator protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr16:30,699,171...30,741,409
Ensembl chr16:30,698,209...30,741,409
G
ST3GAL4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr11:126,355,686...126,414,638
Ensembl chr11:126,355,640...126,440,344
G
STAG3L1
STAG3 cohesin complex component like 1 (pseudogene)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 7:75,359,200...75,367,809
Ensembl chr 7:75,361,374...75,367,087
G
STAT3
signal transducer and activator of transcription 3
IAGP
ClinVar Annotator: match by term: Adenoid cystic carcinoma
ClinVar
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
TLK1
tousled like kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr 2:170,990,823...171,231,293
Ensembl chr 2:170,990,823...171,231,314
G
TOP2A
DNA topoisomerase II alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TP53
tumor protein p53
disease_progression
IEP IAGP EXP
ClinVar Annotator: match by term: Adenocystic carcinoma CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:1673792 PMID:1686725 PMID:6736287 PMID:7707106 PMID:7881428 PMID:7885831 PMID:8023157 PMID:8080050 PMID:8364550 PMID:8869100 PMID:10713666 PMID:10871862 PMID:11479205 PMID:11782540 PMID:11896595 PMID:11920959 PMID:12826609 PMID:14559903 PMID:16322298 PMID:16494995 PMID:16736287 PMID:16818505 PMID:16861262 PMID:17541742 PMID:17606709 PMID:17724467 PMID:18208484 PMID:18818522 PMID:19468865 PMID:20128691 PMID:20407015 PMID:20505364 PMID:20522432 PMID:21343334 PMID:21514416 PMID:21519010 PMID:21626334 PMID:21761402 PMID:22186996 PMID:22915647 PMID:23246812 PMID:23259501 PMID:23625637 PMID:23685749 PMID:24033266 PMID:24384472 PMID:24728327 PMID:25503501 PMID:25584008 PMID:25741868 PMID:25952993 PMID:26230955 PMID:26270727 PMID:26467025 PMID:26585234 PMID:26619011 PMID:27276561 PMID:27463065 PMID:27489289 PMID:27533082 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28369373 PMID:28492532 PMID:28861920 PMID:29070607 PMID:29076966 PMID:29324801 PMID:29470806 PMID:29489754 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30299350 PMID:30327374 PMID:30630526 PMID:30720243 PMID:30840781 PMID:31119730 PMID:31775759 PMID:32019277 PMID:33332384 PMID:33372952 PMID:34805717 PMID:16249115 More...
RGD:8547828
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
UHRF1
ubiquitin like with PHD and ring finger domains 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23685749
NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154
G
VCAN
versican
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
G
WNT5B
Wnt family member 5B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr12:1,617,056...1,647,212
Ensembl chr12:1,529,891...1,647,212
G
XAGE1A
X antigen family member 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24648988
NCBI chr X:52,495,808...52,500,812
Ensembl chr X:52,495,808...52,500,812
G
XRN2
5'-3' exoribonuclease 2
IAGP
DNA:hypermethylation:3' utr: (human)
RGD
PMID:21692051
RGD:11041796
NCBI chr20:21,303,331...21,389,825
Ensembl chr20:21,303,331...21,389,825
G
ZIM2
zinc finger imprinted 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762588
NCBI chr19:56,774,547...56,840,726
Ensembl chr19:56,774,547...56,840,731
G
HNF1A
HNF1 homeobox A
ISO
RGD
PMID:10489374
RGD:150540314
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
G
ATR
ATR serine/threonine kinase
IAGP
ClinVar Annotator: match by term: Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
OMIM ClinVar
PMID:9536098 PMID:15987455 PMID:17010193 PMID:17576681 PMID:18414213 PMID:22341969 PMID:24033266 PMID:25741868 PMID:26845104 PMID:28492532 PMID:28518168 PMID:30262796 PMID:30995915 PMID:32461654 PMID:32522261 PMID:32606146 PMID:33057211 PMID:34008015 More...
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
G
LOC126806830
BRD4-independent group 4 enhancer GRCh37_chr3:142203676-142204875
IAGP
ClinVar Annotator: match by term: Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 3:142,484,834...142,486,033
G
LOC129937703
ATAC-STARR-seq lymphoblastoid active region 20643
IAGP
ClinVar Annotator: match by term: Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 3:142,578,524...142,578,683
G
CXCL8
C-X-C motif chemokine ligand 8
HEP
mRNA:increased expression:head, neck (human)
RGD
PMID:31452775
RGD:150520018
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
ERN1
endoplasmic reticulum to nucleus signaling 1
disease_progression
IEP
RGD
PMID:31187548
RGD:32716423
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
MIR155
microRNA 155
treatment
IDA
RGD
PMID:28347920
RGD:24922223
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR155
microRNA 155
disease_progression
IEP
RGD
PMID:28668836
RGD:24922215
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MTUS1
microtubule associated scaffold protein 1
disease_progression
IEP
RGD
PMID:25885343
RGD:25330345
NCBI chr 8:17,643,802...17,801,521
Ensembl chr 8:17,643,795...17,801,094
G
XRCC4
X-ray repair cross complementing 4
susceptibility
IAGP
DNA:SNP:intron: (rs13180356) (human)
RGD
PMID:26035306
RGD:151361290
NCBI chr 5:83,077,547...83,374,473
Ensembl chr 5:83,077,498...83,353,787
G
CXCL8
C-X-C motif chemokine ligand 8
HEP
mRNA:increased expression:head, neck (human)
RGD
PMID:31452775
RGD:150520018
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
FGFR3
fibroblast growth factor receptor 3
severity
IEP
associated with human papillomavirus;protein:decreased expression:tumor cells (human)
RGD
PMID:30061236
RGD:36947883
NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all